Product Description

Pagoclone 10mg

Pagoclone 10mg is a non-benzodiazepine anxiolytic drug belonging to the cyclopyrrolone class. It acts as a selective partial agonist at the GABA-A receptor, specifically targeting the α2 and α3 subtypes. Developed as a potential treatment for anxiety disorders, Pagoclone was designed to provide anti-anxiety effects with significantly reduced sedation, memory impairment, and dependence risk compared to traditional benzodiazepines.

What is Pagoclone 10mg?

Unlike full agonists like diazepam or alprazolam, Pagoclone produces a milder enhancement of GABA activity. This results in anxiolytic (anti-anxiety) and mild sedative effects while maintaining better cognitive function and lower abuse potential. It was primarily researched for generalized anxiety disorder (GAD), panic disorder, and social anxiety, though it did not receive full regulatory approval in most major markets.

Recommended Dosage and Administration

The standard researched dose of Pagoclone is 10mg taken once or twice daily. Clinical trials typically used doses ranging from 0.3mg to 10mg per day. For anxiety management, it is usually taken orally with or without food. Due to its relatively long half-life (approximately 20–30 hours), once-daily dosing is often sufficient for many patients.

Treatment duration in studies ranged from several weeks to months. It should only be used under medical supervision, and abrupt discontinuation after long-term use may cause withdrawal symptoms, although generally milder than benzodiazepines.

Potential Side Effects

Pagoclone was developed to have a favorable side effect profile. Common side effects include:

• Mild drowsiness or fatigue
• Dizziness
• Headache
• Dry mouth
• Nausea

Compared to benzodiazepines, it causes significantly less sedation, psychomotor impairment, and memory issues. However, some users still report next-day grogginess at higher doses (10mg+). Rare but possible effects include mild coordination problems or mood changes.

Important Precautions and Warnings

Pagoclone is a central nervous system depressant. It should not be combined with alcohol, opioids, other sedatives, or benzodiazepines due to increased risk of respiratory depression and excessive sedation.

It is contraindicated in patients with severe liver or kidney impairment, history of substance abuse, or certain respiratory conditions. Safety during pregnancy and breastfeeding has not been established. Elderly patients may be more sensitive to its effects and usually require lower doses.

Legal Status: Pagoclone is not widely approved for clinical use in most countries (including the US and EU) and is primarily available as a research chemical or in limited jurisdictions.

Pagoclone 10mg Pricing

As a research chemical or limited-market product, pricing varies significantly. A supply of 30 capsules (10mg) typically ranges from $80–$180 depending on the source and purity. Prices are generally higher than common benzodiazepines due to limited availability.

Important Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Pagoclone is not FDA-approved for general medical use in most countries. It should only be used under the supervision of a qualified healthcare provider. Misuse can lead to dependence and other health risks. Consult your doctor or pharmacist before starting, adjusting, or stopping any medication. Individual responses vary significantly.

Additional Information